General Discussion

Sen. Maggie Hassan, D-N.H., on Wednesday questioned the Trump administration over the mystery individual who got exclusive access to a new weight loss drug that is not available to the general public.

Hassan penned a letter to Health and Human Services Secretary Robert F. Kennedy Jr. expressing concern over reports that a “well-connected individual,” whom she suggested is President Donald Trump, received special, free access to the experimental weight loss drug retatrutide.

The New Hampshire Democrat shared the letter with MS NOW in an exclusive interview with “The Weeknight.”

“We’ve got somebody highly connected in this administration who’s making special deals for one person and it just speaks to the whole way this administration operates,” Hassan told MS NOW. “They’re thinking about the highly connected, the wealthy.”

In her letter to Kennedy, the congresswoman said she was concerned that the administration was “bending the rules” by giving an individual special access to the drug through the Food and Drug Administration.

“I am deeply concerned by new reporting that suggests you may be bending the rules of a federal program, and exerting improper political pressure, in order to provide a well-connected individual with free access to an exclusive prescription drug,” the senator wrote to Kennedy.